Needham Reiterates Buy on OrthoPediatrics, Maintains $55 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson has reiterated a 'Buy' rating on OrthoPediatrics (NASDAQ:KIDS) and maintained a $55 price target.

August 01, 2023 | 9:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics' stock rating has been reiterated as 'Buy' by Needham with a maintained price target of $55.
The reiteration of a 'Buy' rating by a reputable analyst like Mike Matson from Needham is a positive signal for investors. The maintained price target of $55 indicates that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100